We have two currently enrolling clinical studies that offer a great opportunity for our patients to receive the most advanced vision treatment possible, generally years before the general public, often at a discounted price and/or with other benefits. Two...
Lifelong Vision Foundation administers clinical studies and funds independent research studies in partnership with the physicians at Pepose Vision Institute, one of the leading ophthalmology practices in the country. These studies play a leading role in the advancement of...
We are pleased to announce our clinical research study designed to evaluate the safety and efficacy of iontophoresis treatment with dexamethasone phosphate ophthalmic solution in patients who have non-infectious anterior segment uveitis. Iontophoresis is an investigational drug delivery system which...
New Clinical study: Announcing a new important clinical trial for wet AMD. This trial will investigate the safety and efficacy of a new, Ranibizumab sustained delivery platform for patients with wet AMD. This is a Genentech Phase II trial...
We are pleased to announce a new study for glaucoma, more specifically, mild or moderate primary open-angle glaucoma. This study is for people that are between the ages of 18 and 85 and need cataract surgery. In this study we’ll use a biodegradable,...
We pleased to announce a new clinical research study that will evaluate the effects and safety of Lampalizumab injection compared to sham procedure in patients with Geographic Atrophy, an advanced form of dry, Age Related Macular Degeneration? There are currently no...
We are pleased to announce the presentation of a fully funded IRB-approved study: A Comparison of Two Commercially Available Genetic Tests for Age-Related Macular Degeneration at the Macula Society Annual Meeting in Southern California. The Macula Society is an...